Ind-Swift Laboratories (NSE:INDSWFTLAB) 5-Year EBITDA Growth Rate : 2.00% (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Ind-Swift Laboratories 5-Year EBITDA Growth Rate?

Ind-Swift Laboratories's EBITDA per Share for the three months ended in Dec. 2023 was ₹9.96.

During the past 12 months, Ind-Swift Laboratories's average EBITDA Per Share Growth Rate was -0.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 10.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 2.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 31.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Ind-Swift Laboratories was 121.40% per year. The lowest was -65.60% per year. And the median was 7.60% per year.

Competitive Comparison of Ind-Swift Laboratories's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Ind-Swift Laboratories's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ind-Swift Laboratories's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ind-Swift Laboratories's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Ind-Swift Laboratories's 5-Year EBITDA Growth Rate falls into.

Ind-Swift Laboratories 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Ind-Swift Laboratories (NSE:INDSWFTLAB) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Ind-Swift Laboratories 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Ind-Swift Laboratories's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ind-Swift Laboratories (NSE:INDSWFTLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ind-Swift Laboratories Ltd (NSE:INDSWFTLAB) » Definitions » 5-Year EBITDA Growth Rate

Traded in Other Exchanges

532305:India

Address

SCO 850, Shivalik Enclave, NAC, Manimajra, Chandigarh, PB, IND, 160 101

Website

https://www.indswiftlabs.com

Ind-Swift Laboratories Ltd is engaged in the business of active pharmaceutical ingredients (API). The company caters to diverse therapeutic segments namely Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Parkinson's Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitor. Geographically, it derives a majority of revenue from Outside India.

Ind-Swift Laboratories (NSE:INDSWFTLAB) Headlines

No Headlines